Literature DB >> 23411750

Inflammatory aortic aneurysm: possible manifestation of IgG4-related sclerosing disease.

Kirtee Raparia1, Claudia P Molina, Gabriela Quiroga-Garza, Donald Weilbaecher, Alberto G Ayala, Jae Y Ro.   

Abstract

In this study, we investigate the hypothesis that IgG4-related autoimmune reaction is involved in the formation of inflammatory aortic aneurysms (IAA). We obtained 23 cases of IAA and 11 cases of atherosclerotic aortic aneurysms (AAA) as control group. We evaluated the expression of IgG4 in both IAA study cases and AAA control cases. In addition, immunohistochemical expression of C-Kit, CD21, CD34, S-100 protein, SMA, vimentin, p53, beta-catenin, and ALK-1, and EBV-LMP1 expression by in situ hybridization were performed only in IAA cases. Of the 23 patients, 20 were males and 3 were females (M: F ratio 6.7:1); age ranged from 43 to 81 years (average 64.3 years). Histologically, all 23 cases of IAA formed a mass that displayed inflammatory myofibroblastic tumor-like features. All lesions stained strongly and diffusely for vimentin and SMA (100%); 17 stained strongly and focally for CD34 (74%); and all were negative for C-Kit, CD21, S-100 protein, p53, beta-catenin, EBV-LMP1, and ALK-1. The numbers of infiltrating IgG4-positive plasma cells in IAA cases exceed that of AAA cases. Score 3 (>50 plasma cells/one 40X field) of IgG4-positive plasma cells was only seen in IAA cases (13/23, 57%), whereas none of the 11 cases of AAA showed score 3 IgG4-positive plasma cells (P=0.0018, Fischer's exact test). Our findings suggest that IAA may be an aortic manifestation of the IgG4-related sclerosing disease. The high number of positive plasma cells, >50 plasma cells/one 40X field is more specific for the IAA than for AAA; however, lesser number can be seen in both IAA and AAA patients.

Entities:  

Keywords:  IgG4 related sclerosing disease; Inflammatory aortic aneurysms; immunohistochemistry

Mesh:

Substances:

Year:  2013        PMID: 23411750      PMCID: PMC3563203     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms.

Authors:  S Halme; T Juvonen; A Laurila; J Juvonen; M Mosorin; P Saikku; H M Surcel
Journal:  Eur J Clin Invest       Date:  1999-06       Impact factor: 4.686

2.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.

Authors:  John H Stone; Arezou Khosroshahi; Vikram Deshpande; John K C Chan; J Godfrey Heathcote; Rob Aalberse; Atsushi Azumi; Donald B Bloch; William R Brugge; Mollie N Carruthers; Wah Cheuk; Lynn Cornell; Carlos Fernandez-Del Castillo; Judith A Ferry; David Forcione; Günter Klöppel; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Yasufumi Masaki; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant Sahani; Yasuharu Sato; Thomas Smyrk; James R Stone; Masayuki Takahira; Hisanori Umehara; George Webster; Motohisa Yamamoto; Eunhee Yi; Tadashi Yoshino; Giuseppe Zamboni; Yoh Zen; Suresh Chari
Journal:  Arthritis Rheum       Date:  2012-10

3.  Possible involvement of myofibroblast in the development of inflammatory aortic aneurysm.

Authors:  Noriyuki Sakata; Kazuki Nabeshima; Hiroshi Iwasaki; Tadashi Tashiro; Noriko Uesugi; Osamu Nakashima; Hiroyuki Ito; Takemi Kawanami; Kiyomi Furuya; Masaru Kojima
Journal:  Pathol Res Pract       Date:  2006-11-15       Impact factor: 3.250

4.  Sensitivity and specificity of CT in the diagnosis of inflammatory abdominal aortic aneurysms.

Authors:  Misako Iino; Sachio Kuribayashi; Satoshi Imakita; Makoto Takamiya; Hiroshi Matsuo; Yutaka Ookita; Motomi Ando; Hatsue Ueda
Journal:  J Comput Assist Tomogr       Date:  2002 Nov-Dec       Impact factor: 1.826

5.  Splenic inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunophenotypic study of 12 cases.

Authors:  T S Neuhauser; G A Derringer; L D Thompson; J C Fanburg-Smith; N S Aguilera; J Andriko; W S Chu; S L Abbondanzo
Journal:  Arch Pathol Lab Med       Date:  2001-03       Impact factor: 5.534

6.  Inflammatory aneurysms of the abdominal aorta.

Authors:  D I Walker; K Bloor; G Williams; I Gillie
Journal:  Br J Surg       Date:  1972-08       Impact factor: 6.939

7.  Inflammatory abdominal aortic aneurysm.

Authors:  David B Hellmann; David J Grand; Julie A Freischlag
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

8.  Features of autoimmunity in the abdominal aortic aneurysm.

Authors:  A K Gregory; N X Yin; J Capella; S Xia; K M Newman; M D Tilson
Journal:  Arch Surg       Date:  1996-01

9.  Chronic periaortitis and periarteritis.

Authors:  M J Mitchinson
Journal:  Histopathology       Date:  1984-07       Impact factor: 5.087

10.  Retroperitoneal fibrosis and chronic periaortitis: a new hypothesis.

Authors:  F B Martina; R Nüech; T C Gasser
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

View more
  4 in total

1.  The many faces of IgG4-related disease: report of a case with inaugural recurrent aortic aneurism ruptures and literature review.

Authors:  Mariana Luís; Luísa Brites; Bruno Fernandes; Diogo Jesus; Tânia Santiago; Sara Serra; João Rovisco; Lina Carvalho; José António P da Silva; Armando Malcata
Journal:  Rheumatol Int       Date:  2018-05-12       Impact factor: 2.631

2.  Inflammatory thoracic aortic aneurysm (lymphoplasmacytic thoracic aortitis): a 13-year-experience at a German Heart Center with emphasis on possible role of IgG4.

Authors:  Abbas Agaimy; Michael Weyand; Thomas Strecker
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

3.  Abdominal aortic aneurysm as an IgG4-related disease.

Authors:  M Prucha; P Sedivy; P Stadler; P Zdrahal; P Prokopova; L Voska; L Sedlackova
Journal:  Clin Exp Immunol       Date:  2019-05-14       Impact factor: 4.330

Review 4.  Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.

Authors:  Hanrong Li; Shuling Bai; Qiang Ao; Xiaohong Wang; Xiaohong Tian; Xiang Li; Hao Tong; Weijian Hou; Jun Fan
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.